✦ New CED Clinical Relevance #70Notable Clinical Interest Emerging findings or policy developments worth monitoring closely. ⚒ Cannabis News | CED Clinic Pediatric EpilepsyCbdSeizure DisordersPolicyAccess Why This MattersCBD access for pediatric seizure disorders remains legally complex...
Medical Cannabis Evidence Map: Broad Promise, Variable Proof
When considering only high-quality systematic reviews, as evaluated by the AMSTAR 2 tool, 42 out of 67 descriptions of treatment effects for up to 20 health outcomes were classified as ‘Positive’ or ‘Potentially Positive.’ These outcomes included pain, insomnia, seizures, anxiety, muscle spasticity, multiple sclerosis, urinary incontinence, anorexia, and patient safety.
Cannabidiol & Cortical Excitability: Clinical Trial Results
Clinical Takeaway In a controlled crossover trial of healthy males, neither a low (30 mg) nor a high (700 mg) single dose of CBD produced measurable changes in cortical excitability compared to...
Cannabinoid Clinical Trials: CBD and Cortical Excitability
Clinical Takeaway In a controlled crossover trial of healthy men, neither a low (30 mg) nor a high (700 mg) single dose of CBD directly altered cortical excitability compared to placebo. This...
Cannabinoid Clinical Trials: CBD Cortical Excitability Study
Clinical Takeaway In this randomized, double-blind, placebo-controlled crossover trial in healthy males, neither a low nor a high single dose of CBD produced measurable changes in cortical excitability compared to placebo. This...
Cannabinoids in Pediatric Medicine: Evidence-Based Review
Clinical Takeaway Cannabinoids have been studied across a range of pediatric medical conditions, with evidence drawn from interventional trials, observational studies, and patient surveys. The current body of research supports cautious clinical...
Cannabidiol for Lennox-Gastaut: Cannabinoid Clinical Trials
Clinical Takeaway Plant-derived cannabidiol (CBD) oral solution produced meaningful reductions in drop seizures in patients with Lennox-Gastaut syndrome at thresholds below the traditional 50% benchmark used in clinical trials. Caregiver-reported outcomes aligned...